Related Experiment Video
Updated: May 14, 2026

A Detailed Protocol for Perspiration Monitoring Using a Novel, Small, Wireless Device
Published on: November 24, 2016
Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders
Nelson Wolosker1, Mariana Krutman, Taiz Pereira Donozo Almeida Campdell
1Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Low-dose oxybutynin effectively treats palmar and axillary hyperhidrosis in both men and women. This study found similar improvements in quality of life and symptom severity across genders.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Hyperhidrosis, a condition causing excessive sweating, affects both palmar and axillary regions.
- Current treatments for hyperhidrosis have varying efficacy and side effect profiles.
Purpose of the Study:
- To evaluate the effectiveness of low-dose oxybutynin for treating palmar and axillary hyperhidrosis.
- To compare treatment outcomes between male and female patients.
Main Methods:
- Retrospective analysis of 395 women and 170 men with palmar and axillary hyperhidrosis.
- Patients were treated with low doses of oxybutynin.
Main Results:
- 70% of patients experienced partial or significant improvement in hyperhidrosis.
- 40% of female patients reported "great" improvement; overall quality of life improved for approximately 70% of all patients.
- 30% of patients reported no change in their condition.
Conclusions:
- Oxybutynin treatment for hyperhidrosis shows similar efficacy in both genders.
- Gender does not significantly impact the results of oxybutynin therapy for hyperhidrosis.
- Significant improvements in quality of life were observed in both male and female patients.
Related Concept Videos
Comparative Excretory Systems
Urodynamic Studies: Uroflowmetry
Physiology of the Genitourinary System III: Urine Concentration and Dilution
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi III: Medical Management
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...